Copy
View this email in your browser

ODPRN Newsletter

Spring 2019
The ODPRN Newsletters feature important research, news and opportunities related to drug policy in Ontario.
In This Issue
Recently Released | ODPRN In The News
Patient Engagement | Career Opportunities
Upcoming Research | Other News

Recently Released

Naloxone Distribution Across Ontario: A brief report

This study aimed to measure the uptake of naloxone through both the pharmacy- and community- based programs in Ontario and to assess if distribution benchmarks were achieved based on observed opioid-related harms across public health units in the province.

Opioid Use Among First Nations in Ontario: A report of current findings

This collaborative report was prepared by ICES, the Chiefs of Ontario and ODPRN for the Chiefs in Assembly, to provide information on prescription opioid use and opioid-related harms among First Nations people in Ontario.

Quality of primary care among individuals receiving treatment for opioid use disorder

This study examines whether people receiving opioid agonist therapy are also receiving high-quality primary care compared to the general population. This was measured by exploring the prevalence of cancer screening and diabetes monitoring. 

Ontario Prescription Opioid Tool: Update March 2019

The Ontario Prescription Opioid Tool allows public access to data related to indicators for opioid prescribing in the province. This tool was recently updated to include data up to December 2018 and a breakdown of pharmacy-dispensed naloxone by type (injectable and intranasal). The next update is scheduled for the end of June 2019.

ODPRN in the News

London area ranks third in province for naloxone distribution rate

Of the 147,303 publicly funded naloxone kits distributed across the province between July 2017 and June 2018, 8,657 were handed out in the Middlesex-London Health Unit coverage area — a rate of 1,813 per 100,000 people — a new study by the Ontario Drug Policy Research Network says.

Three research teams at St. Michael’s to receive federal funding to address the opioid crisis
Federal Health Minister Ginette Petitpas Taylor was at St. Michael’s Hospital on Wednesday morning to announce $10.7 million in funding to support a number of new initiatives focused on addressing Canada’s opioid crisis.

Patient Engagement

Join Our Citizens' Panel!
The ODPRN is looking for individuals to join our Citizens' Panel. As a member, you will have the opportunity to provide feedback on drug policy research in Ontario. Through this role, you will help us to better understand what matters most to people with respect to healthcare policy in Ontario. Members are compensated for their time.

If you are interested in becoming a member, please email Dana Shearer at shearerd@smh.ca for more information.


Take-home Naloxone: A Qualitative Study of Accessibility
We are interested in hearing from individuals across Ontario on their experiences accessing naloxone, including what makes it easier or more difficult to access this product. We have expanded this study to include individuals who do NOT have personal experience with opioids (i.e. family members, friends, community members). We are also still looking for a few more individuals who take opioids for chronic pain management.

If you or someone you know are interested in participating in this study, please
call us at 1-888-316-3776. Participants will be compensated for their time.

Student and Career Opportunities

Research Analyst - Two year, full-time contract

The ODPRN is seeking a motivated and collaborative research analyst to work collaboratively with the ODPRN team and principal investigators (PI) to provide epidemiologic and analytic expertise for our projects. The research analyst will report to the research program manager in the Chronic Disease and Pharmacotherapy (CDP) Research Program within the ICES Research and Analysis Department. The successful candidate will work collaboratively with ICES researchers, applying research methodology and knowledge of epidemiology in the context of health services administrative data.

Full details and application requirements here.

Sneak Peek: Upcoming Research
The Opioid Mortality Surveillance Report
The ODPRN, the Office of the Chief Coroner for Ontario and Public Health Ontario have co-published a report that describes the current trends and characteristics of confirmed opioid-related deaths in Ontario between July 1, 2017 and June 30, 2018. Key knowledge users representing the Office of the Chief Medical Officer of Health, local public health units, community health centres and people with lived experience of pain or substance use informed the development of the report. The report and associated materials will be released on June 17, 2019.
Other News Related to Drug Policy in Ontario
New data available on home care and mental health and addictions
Canadian Institute for Health Information | May 30, 2019

Ontario Health Team: FAQs
Ontario Medical Association | May 17, 2019

Government of Canada approves new treatment options for opioid use disorder and supports research, treatment and harm reduction projects in Ontario
Health Canada | May 15, 2019

Changes to the OHIP+ Program
Ontario Pharmacists Association | April 1, 2019

Ontario Continuing to Build a Connected Mental Health and Addictions Treatment System
Ministry of Health and Long-Term Care | March 29, 2019

Interactive Opioid Tool Update: Opioid-related morbidity and mortality in Ontario
Public Health Ontario | March 20, 2019

Budget 2019: Moving Forward on Implementing National Pharmacare
Government of Canada | March 19, 2019
Share
Tweet
Connect
Learn More
Contact Us
Copyright © 2016 ODPRN, All rights reserved.

St. Michael's Hospital, 30 Bond Street 
Toronto, ON M5B 1W8, Canada


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Ontario Drug Policy Research Network · St. Michael's Hospital c/o Applied Health Research Centre · 30 Bond St. · Toronto, On M5B 1W8 · Canada

Email Marketing Powered by Mailchimp